MAP1LC3A and Parkinson disease: It has been shown that overexpression of miR-133a inhibits MPP+-induced autophagy (MAP1LC3A/MAP1LC3B, BECN1, NUP62) in a cellular model of Parkinson’s disease [64], and downregulation of miR-17-5p inhibits infarction-induced myocardial autophagy [65].